Global Solid Tumor Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08253138

Publication Date:

August 19, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Solid tumor testing is a medical procedure that helps in the early detection of cancer. It is done to avoid the spread of cancerous cells throughout the body and allow for effective treatment.
The global Solid Tumor Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淪olid Tumor Testing Industry Forecast鈥� looks at past sales and reviews total world Solid Tumor Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Solid Tumor Testing sales for 2024 through 2030. With Solid Tumor Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Tumor Testing industry.
This Insight Report provides a comprehensive analysis of the global Solid Tumor Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Tumor Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Solid Tumor Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Tumor Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Tumor Testing.
Hospitals will be the primary end-user to the solid tumor testing market in the global till the end of 2025. Factors such as growing incidences of the tumor and terminal illnesses will drive the patients to visit hospitals for tumor testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Tumor Testing market by product type, application, key players and key regions and countries.
Segmentation by type
Conventional Testing
Non-Conventional Testing
Segmentation by application
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Danaher
F. Hoffmann-La Roche
Agilent Technologies
Thermo Fisher Scientific
Illumina

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Solid Tumor Testing Market Size 2019-2030
2.1.2 Solid Tumor Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Solid Tumor Testing Segment by Type
2.2.1 Conventional Testing
2.2.2 Non-Conventional Testing
2.3 Solid Tumor Testing Market Size by Type
2.3.1 Solid Tumor Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Solid Tumor Testing Market Size Market Share by Type (2019-2024)
2.4 Solid Tumor Testing Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Academic and Research Institutes
2.4.4 Others
2.5 Solid Tumor Testing Market Size by Application
2.5.1 Solid Tumor Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Solid Tumor Testing Market Size Market Share by Application (2019-2024)
3 Solid Tumor Testing Market Size by Player
3.1 Solid Tumor Testing Market Size Market Share by Players
3.1.1 Global Solid Tumor Testing Revenue by Players (2019-2024)
3.1.2 Global Solid Tumor Testing Revenue Market Share by Players (2019-2024)
3.2 Global Solid Tumor Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Solid Tumor Testing by Regions
4.1 Solid Tumor Testing Market Size by Regions (2019-2024)
4.2 Americas Solid Tumor Testing Market Size Growth (2019-2024)
4.3 APAC Solid Tumor Testing Market Size Growth (2019-2024)
4.4 Europe Solid Tumor Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Solid Tumor Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Solid Tumor Testing Market Size by Country (2019-2024)
5.2 Americas Solid Tumor Testing Market Size by Type (2019-2024)
5.3 Americas Solid Tumor Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Solid Tumor Testing Market Size by Region (2019-2024)
6.2 APAC Solid Tumor Testing Market Size by Type (2019-2024)
6.3 APAC Solid Tumor Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Solid Tumor Testing by Country (2019-2024)
7.2 Europe Solid Tumor Testing Market Size by Type (2019-2024)
7.3 Europe Solid Tumor Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Solid Tumor Testing by Region (2019-2024)
8.2 Middle East & Africa Solid Tumor Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Solid Tumor Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Solid Tumor Testing Market Forecast
10.1 Global Solid Tumor Testing Forecast by Regions (2025-2030)
10.1.1 Global Solid Tumor Testing Forecast by Regions (2025-2030)
10.1.2 Americas Solid Tumor Testing Forecast
10.1.3 APAC Solid Tumor Testing Forecast
10.1.4 Europe Solid Tumor Testing Forecast
10.1.5 Middle East & Africa Solid Tumor Testing Forecast
10.2 Americas Solid Tumor Testing Forecast by Country (2025-2030)
10.2.1 United States Solid Tumor Testing Market Forecast
10.2.2 Canada Solid Tumor Testing Market Forecast
10.2.3 Mexico Solid Tumor Testing Market Forecast
10.2.4 Brazil Solid Tumor Testing Market Forecast
10.3 APAC Solid Tumor Testing Forecast by Region (2025-2030)
10.3.1 China Solid Tumor Testing Market Forecast
10.3.2 Japan Solid Tumor Testing Market Forecast
10.3.3 Korea Solid Tumor Testing Market Forecast
10.3.4 Southeast Asia Solid Tumor Testing Market Forecast
10.3.5 India Solid Tumor Testing Market Forecast
10.3.6 Australia Solid Tumor Testing Market Forecast
10.4 Europe Solid Tumor Testing Forecast by Country (2025-2030)
10.4.1 Germany Solid Tumor Testing Market Forecast
10.4.2 France Solid Tumor Testing Market Forecast
10.4.3 UK Solid Tumor Testing Market Forecast
10.4.4 Italy Solid Tumor Testing Market Forecast
10.4.5 Russia Solid Tumor Testing Market Forecast
10.5 Middle East & Africa Solid Tumor Testing Forecast by Region (2025-2030)
10.5.1 Egypt Solid Tumor Testing Market Forecast
10.5.2 South Africa Solid Tumor Testing Market Forecast
10.5.3 Israel Solid Tumor Testing Market Forecast
10.5.4 Turkey Solid Tumor Testing Market Forecast
10.5.5 GCC Countries Solid Tumor Testing Market Forecast
10.6 Global Solid Tumor Testing Forecast by Type (2025-2030)
10.7 Global Solid Tumor Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Solid Tumor Testing Product Offered
11.1.3 BD Solid Tumor Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Solid Tumor Testing Product Offered
11.2.3 Danaher Solid Tumor Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Information
11.3.2 F. Hoffmann-La Roche Solid Tumor Testing Product Offered
11.3.3 F. Hoffmann-La Roche Solid Tumor Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 F. Hoffmann-La Roche Main Business Overview
11.3.5 F. Hoffmann-La Roche Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Solid Tumor Testing Product Offered
11.4.3 Agilent Technologies Solid Tumor Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Solid Tumor Testing Product Offered
11.5.3 Thermo Fisher Scientific Solid Tumor Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Illumina
11.6.1 Illumina Company Information
11.6.2 Illumina Solid Tumor Testing Product Offered
11.6.3 Illumina Solid Tumor Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Illumina Main Business Overview
11.6.5 Illumina Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂